- Hexamethylmelamine as Consolidation Treatment for Patients with Advanced Epithelial Ovarian Cancer in Complete Response after First-Line Chemotherapy
-
Kwon YS, Nam JH, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT
- KMID: 1779203
- J Korean Med Sci.
- 2009 Aug;24(4):679-683.
- doi: 10.3346/jkms.2009.24.4.679
The aim of this study was to assess the efficacy of consolidation therapy with hexamethylmelamine (HMM) in patients with advanced epithelial ovarian cancer (EOC). Patients treated at our hospital between... -
- CITED
-
- Close
- SHARE
-
- Close
- A Combination of Melphalan, Prednisone, and 50 mg Thalidomide Treatment in Non-Transplant-Candidate Patients with Newly Diagnosed Multiple Myeloma
-
Chang HJ, Lee JH, Do YR, Bae SH, Lee JL, Nam SH, Yoon SS, Bang SM
- KMID: 1729242
- Korean J Intern Med.
- 2011 Dec;26(4):403-409.
- doi: 10.3904/kjim.2011.26.4.403
BACKGROUND/AIMS: The clinical efficacy and safety of a three-drug combination of melphalan, prednisone, and thalidomide were assessed in patients with multiple myeloma who were not candidates for high-dose therapy as... -
- CITED
-
- Close
- SHARE
-
- Close
- Prediction of Response to Concurrent Chemoradiotherapy with Temozolomide in Glioblastoma: Application of Immediate Post-Operative Dynamic Susceptibility Contrast and Diffusion-Weighted MR Imaging
-
Lee EK, Choi SH, Yun TJ, Kang KM, Kim TM, Lee SH, Park CK, Park SH, Kim IH
- KMID: 2344290
- Korean J Radiol.
- 2015 Dec;16(6):1341-1348.
- doi: 10.3348/kjr.2015.16.6.1341
OBJECTIVE: To determine whether histogram values of the normalized apparent diffusion coefficient (nADC) and normalized cerebral blood volume (nCBV) maps obtained in contrast-enhancing lesions detected on immediate post-operative MR imaging... -
- CITED
-
- Close
- SHARE
-
- Close
- High Dose Therapy Followed by Autologous Peripheral Blood Stem Cell Transplantation as a First Line Treatment for Multiple Myeloma: a Korean Multicenter Study
-
Bang SM, Cho EK, Suh C, Yoon SS, Seong CM, Cho KS, Kang YG, Park S, Ahn MJ, Park YS, Oh D, Kim HC, Jung CW, Kim S, Lee JH
- KMID: 1130037
- J Korean Med Sci.
- 2003 Oct;18(5):673-678.
- doi: 10.3346/jkms.2003.18.5.673
We conducted a phase II multicenter trial to estimate the response and survival of patients with newly diagnosed multiple myeloma to high dose melphalan therapy followed by autologous peripheral blood... -
- CITED
-
- Close
- SHARE
-
- Close
